These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 547789)

  • 1. [Systemic immunological monitoring of patients with laryngeal carcinoma: humoral immunity].
    Bussi M; Cortesina G; Sartoris A; Morra B; Tabaro G
    Ann Laringol Otol Rinol Faringol; 1979; 77(1-2):89-97. PubMed ID: 547789
    [No Abstract]   [Full Text] [Related]  

  • 2. [Systematic immunological monitoring of patients with laryngeal cancer: cell-mediated immunity].
    Sartoris A; Cortesina G; Morra B; Bussi M; Tabaro G
    Ann Laringol Otol Rinol Faringol; 1979; 77(1-2):81-7. PubMed ID: 547788
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of function studies in the immunological assessment of laryngeal cancer patients].
    Denaro A; Caruso R; Rossi M; Campo M; Iacona G; Mangano A; Stivala F
    Acta Otorhinolaryngol Ital; 1983; 3(6):625-39. PubMed ID: 6675414
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of concomitant pathology and radiation treatment on the immunity indices of patients with laryngeal cancer].
    Bulbuk GA; Tsybyrné GA; Mazur LN; Dariĭ VA
    Vopr Onkol; 1989; 35(5):608-12. PubMed ID: 2741432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systematic immunological monitoring of patients with laryngeal cancer: prospects and limitations].
    Cortesina G; Sartoris A; Morra B; Bussi M; Tabaro G
    Ann Laringol Otol Rinol Faringol; 1979; 77(1-2):77-80. PubMed ID: 547787
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic monitoring in patients with laryngeal cancer. Critical considerations on the current possibilities of clinical application].
    Menzio P; Cortesina G; Sartoris A; Bussi M; Morra B; Cavallo GP; Beatrice F; Di Fortunato V; Poggio E
    Minerva Med; 1982 Apr; 73(18):1251-4. PubMed ID: 7078804
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological study of laryngeal neoplasm cases].
    Filiaci F; Luzi G; Stirpe G; Di Gangi A
    Riv Med Aeronaut Spaz; 1979; 42(1-2):186-93. PubMed ID: 317977
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of humoral and cellular resistance in children with laryngeal papillomatosis.
    Jakubíková J; Oravec C; Klacanský I
    Int J Pediatr Otorhinolaryngol; 1992 May; 23(3):229-36. PubMed ID: 1592559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indicators of resistance to infection in children with respiratory papillomatosis].
    Ashurov ZM; Savitskaia KI; Rusanova EV; Shevtsov VV; Vozhagov VV; Musatenko LIu
    Vestn Otorinolaringol; 1996; (4):28-31. PubMed ID: 8966874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of red-cell immunology in patients with laryngeal carcinoma].
    Sun Y; Liu Y; Liu Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(6):351-3. PubMed ID: 8762526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Humoral and cellular immune response in psoriasis].
    Ruszczak Z; Ciborska L; Czarnecki M; Bednarowicz G
    Z Hautkr; 1986 Mar; 61(6):366-76. PubMed ID: 3705661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cellular immunity in long-term surviving patients with malignant lymphoma.
    Opat P; Kolár V; Lauerová L; Pintera J; Zemanová D
    Neoplasma; 1980; 27(3):301-6. PubMed ID: 7453850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does an immune reactivity to human laryngeal cancer exist?].
    Cortesina G; Cavallo GP; Sartoris A; Beatrice F; Morra B; Bussi M; Poggio E
    G Batteriol Virol Immunol; 1979; 72(1-6):169-90. PubMed ID: 399929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI; Lukach EV; Krivokhatskaia LD
    Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rosette-forming capacity of lymphocytes and lymphoid infiltration of the tumor stroma as indicators of immunologic homeostasis in patients with laryngeal cancer].
    Ladniuk PB; Shargorodskaia AZ; Dorosevich AE
    Vestn Otorinolaringol; 1983; (3):46-8. PubMed ID: 6603046
    [No Abstract]   [Full Text] [Related]  

  • 16. [T and B lymphocytes in laryngeal carcinoma].
    Zezula J; Rejtnar A; Sůva P
    Cesk Otolaryngol; 1981 Apr; 30(2):70-4. PubMed ID: 6972271
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-immunological correlations in psoriatic arthritis based on data from determining cellular (T- and B-lymphocytes) and humoral (IgG, IgA and IgM) immunity factors].
    Nikulin NK; Starostina ZD; Komarova VD
    Vestn Dermatol Venerol; 1981 Sep; (9):10-4. PubMed ID: 6975543
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological status of laryngeal cancer patients and the problems of nonspecific immunotherapy].
    Nasretdinov TKh; Gorodilova VV; Pogosov VS; Akopian RG
    Vestn Otorinolaringol; 1981; (4):56-61. PubMed ID: 7303375
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological reactivity of patients with acute disorders of cerebral circulation].
    Erokhina GR; Gannushkina IV; Pulatov AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):995-1001. PubMed ID: 3499731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck].
    Bulbuk GA
    Vopr Onkol; 1982; 28(4):57-9. PubMed ID: 7090271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.